Kwangho Lee

Person

Waltham, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Ligand-directed covalent modification of protein
- Patent number 11,542,492
- Issue date Jan 3, 2023
- Celgene CAR LLC
- Russell C. Petter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Salts of an epidermal growth factor receptor kinase inhibitor
- Patent number 9,540,335
- Issue date Jan 10, 2017
- Celgene Avilomics Research, Inc.
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,4-disubstituted pyrimidine compounds useful as kinase inhibtors
- Patent number 9,375,431
- Issue date Jun 28, 2016
- Celgene Avilomics Research, Inc.
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds and uses thereof
- Patent number 9,238,629
- Issue date Jan 19, 2016
- Celgene Avilomics Research, Inc.
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts of an epidermal growth factor receptor kinase inhibitor
- Patent number 9,108,927
- Issue date Aug 18, 2015
- Celgene Avilomics Research, Inc.
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and uses thereof
- Patent number 8,975,249
- Issue date Mar 10, 2015
- Celgene Avilomics Research, Inc.
- Kwangho Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mutant-selective EGFR inhibitors and uses thereof
- Patent number 8,796,255
- Issue date Aug 5, 2014
- Celgene Avilomics Research, Inc.
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Ligand-Directed Covalent Modification of Protein
- Publication number 20170218353
- Publication date Aug 3, 2017
- Celgene CAR LLC
- Russell C. Petter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
- Publication number 20150344441
- Publication date Dec 3, 2015
- CELGENE AVILOMICS RESEARCH, INC.
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20150246040
- Publication date Sep 3, 2015
- CELGENE AVILOMICS RESEARCH, INC.
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
- Publication number 20130267531
- Publication date Oct 10, 2013
- CELGENE AVILOMICS RESEARCH, INC.
- Mei Lai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MUTANT-SELECTIVE EGFR INHIBITORS AND USES THEREOF
- Publication number 20120157426
- Publication date Jun 21, 2012
- AVILA THERAPEUTICS, INC.
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20120149687
- Publication date Jun 14, 2012
- AVILA THERAPEUTICS, INC.
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20120149722
- Publication date Jun 14, 2012
- AVILA THERAPEUTICS, INC.
- Kwangho Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN
- Publication number 20110269244
- Publication date Nov 3, 2011
- Russell C. Petter
- C07 - ORGANIC CHEMISTRY

Kwangho Lee

Person

Patents Grantslast 30 patents

Ligand-directed covalent modification of protein

Salts of an epidermal growth factor receptor kinase inhibitor

2,4-disubstituted pyrimidine compounds useful as kinase inhibtors

Heteroaryl compounds and uses thereof

Salts of an epidermal growth factor receptor kinase inhibitor

Heterocyclic compounds and uses thereof

Mutant-selective EGFR inhibitors and uses thereof

Patents Applicationslast 30 patents

Ligand-Directed Covalent Modification of Protein

SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR

HETEROCYCLIC COMPOUNDS AND USES THEREOF

SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR

MUTANT-SELECTIVE EGFR INHIBITORS AND USES THEREOF

HETEROCYCLIC COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN